97 related articles for article (PubMed ID: 29654619)
1. Overexpression of ZAKβ in human osteosarcoma cells enhances ZAKα expression, resulting in a synergistic apoptotic effect.
Fu CY; Tseng YS; Chen MC; Hsu HH; Yang JJ; Tu CC; Lin YM; Viswanadha VP; Ding K; Kuo WW; Huang CY
Cell Biochem Funct; 2018 Jun; 36(4):176-182. PubMed ID: 29654619
[TBL] [Abstract][Full Text] [Related]
2. ZAKβ antagonizes and ameliorates the cardiac hypertrophic and apoptotic effects induced by ZAKα.
Fu CY; Kuo WW; Ho TJ; Wen SY; Lin LC; Tseng YS; Hung HC; Viswanadha VP; Yang JJ; Huang CY
Cell Biochem Funct; 2016 Dec; 34(8):606-612. PubMed ID: 27859413
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin induces ZAKα overexpression with a subsequent enhancement of apoptosis and attenuation of survivability in human osteosarcoma cells.
Fu CY; Tseng YS; Chen MC; Hsu HH; Yang JJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):191-197. PubMed ID: 29105997
[TBL] [Abstract][Full Text] [Related]
4. Antitumorigenic Effects of ZAKβ, an Alternative Splicing Isoform of ZAK.
Lee JS; Lin YY; Wang TS; Liu JY; Lin WW; Yang JJ
Chin J Physiol; 2018 Feb; 61(1):25-34. PubMed ID: 29374956
[TBL] [Abstract][Full Text] [Related]
5. Selective Activation of ZAK β Expression by 3-Hydroxy-2-Phenylchromone Inhibits Human Osteosarcoma Cells and Triggers Apoptosis via JNK Activation.
Fu CY; Lay IS; Shibu MA; Tseng YS; Kuo WW; Yang JJ; Wang TF; Bharath BM; Yeh YL; Huang CY
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397561
[TBL] [Abstract][Full Text] [Related]
6. ZAKβ Alleviates Oxidized Low-density Lipoprotein (ox-LDL)-Induced Apoptosis and B-type Natriuretic Peptide (BNP) Upregulation in Cardiomyoblast.
Lin YM; Situmorang JH; Guan JZ; Hsieh DJ; Yang JJ; Chen MY; Loh CH; Kuo CH; Lu SY; Liou YM; Huang CY
Cell Biochem Biophys; 2022 Sep; 80(3):547-554. PubMed ID: 35776316
[TBL] [Abstract][Full Text] [Related]
7. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Curcumin on ZAKα Activity Resultant in Apoptosis and Anchorage-Independent Growth in Cancer Cells.
Lee JS; Wang TS; Lin MC; Lin WW; Yang JJ
Chin J Physiol; 2017 Oct; 60(5):267-274. PubMed ID: 28950690
[TBL] [Abstract][Full Text] [Related]
10. Myofibrillar myopathy hallmarks associated with ZAK deficiency.
Stonadge A; Genzor AV; Russell A; Hamed MF; Romero N; Evans G; Pownall ME; Bekker-Jensen S; Blanco G
Hum Mol Genet; 2023 Aug; 32(17):2751-2770. PubMed ID: 37427997
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
[TBL] [Abstract][Full Text] [Related]
12. Sensitizing osteosarcoma stem cells to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins.
Gonçalves C; Martins-Neves SR; Paiva-Oliveira D; Oliveira VE; Fontes-Ribeiro C; Gomes CM
Life Sci; 2015 Jun; 130():47-56. PubMed ID: 25818183
[TBL] [Abstract][Full Text] [Related]
13. A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro.
Rathore K; Cekanova M
Drug Des Devel Ther; 2015; 9():5323-35. PubMed ID: 26451087
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif.
Liu TC; Huang CJ; Chu YC; Wei CC; Chou CC; Chou MY; Chou CK; Yang JJ
Biochem Biophys Res Commun; 2000 Aug; 274(3):811-6. PubMed ID: 10924358
[TBL] [Abstract][Full Text] [Related]
15. ZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cells.
Sauter KA; Magun EA; Iordanov MS; Magun BE
Cancer Biol Ther; 2010 Aug; 10(3):258-66. PubMed ID: 20559024
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Castro-Gamero AM; Borges KS; da Silva Silveira V; Lira RC; de Paula Gomes Queiroz R; Valera FC; Scrideli CA; Umezawa K; Tone LG
Anticancer Drugs; 2012 Jul; 23(6):638-50. PubMed ID: 22382389
[TBL] [Abstract][Full Text] [Related]
17. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
18. Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy?
Yao C; Wei JJ; Wang ZY; Ding HM; Li D; Yan SC; Yang YJ; Gu ZP
Cell Biochem Biophys; 2013 Mar; 65(2):217-27. PubMed ID: 23015227
[TBL] [Abstract][Full Text] [Related]
19. ERβ targets ZAK and attenuates cellular hypertrophy via SUMO-1 modification in H9c2 cells.
Pai P; Shibu MA; Chang RL; Yang JJ; Su CC; Lai CH; Liao HE; Viswanadha VP; Kuo WW; Huang CY
J Cell Biochem; 2018 Sep; 119(9):7855-7864. PubMed ID: 29932238
[TBL] [Abstract][Full Text] [Related]
20. Nudol, a phenanthrene derivative from
Zhang Y; Zhang Q; Xin W; Liu N; Zhang H
Drug Des Devel Ther; 2019; 13():2591-2601. PubMed ID: 31551653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
